VFMFX | VMVAX | VFMFX / VMVAX | |
Total Expense Ratio | 0.18 | 0.07 | 257% |
Annual Report Gross Expense Ratio | 0.18 | 0.07 | 257% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 4.762 | 5.198 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 50000 | 3000 | 1,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 184M | 31B | 1% |
Annual Yield % from dividends | 1.77 | 2.22 | 79% |
Returns for 1 year | 7.03 | 7.67 | 92% |
Returns for 3 years | 33.53 | 17.51 | 192% |
Returns for 5 years | 83.90 | 65.15 | 129% |
Returns for 10 years | N/A | 87.87 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PIIQX | 13.48 | 0.07 | +0.52% |
Principal International Equity Index R5 | |||
GQHPX | 13.29 | 0.03 | +0.23% |
GQG Partners US Quality Value Fund Inv | |||
RYPDX | 127.24 | 0.19 | +0.15% |
Rydex Consumer Products A | |||
JGAQX | 38.02 | -0.16 | -0.42% |
JPMorgan Value Advantage R2 | |||
LAVQX | 15.77 | -0.09 | -0.57% |
Lord Abbett Fundamental Equity R2 |